 Maria Nagel
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 71 | 2024 | 330 | 18.680 |
Why?
| | Herpes Zoster | 44 | 2024 | 317 | 11.390 |
Why?
| | Temporal Arteries | 17 | 2021 | 45 | 5.840 |
Why?
| | Giant Cell Arteritis | 13 | 2021 | 47 | 5.310 |
Why?
| | DNA, Viral | 14 | 2024 | 348 | 3.240 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 211 | 2.730 |
Why?
| | Cerebral Arteries | 8 | 2021 | 57 | 2.660 |
Why?
| | Encephalitis, Varicella Zoster | 9 | 2016 | 17 | 2.590 |
Why?
| | Varicella Zoster Virus Infection | 6 | 2024 | 25 | 2.440 |
Why?
| | Virus Diseases | 8 | 2022 | 209 | 2.280 |
Why?
| | Stroke | 10 | 2023 | 1063 | 2.270 |
Why?
| | Chickenpox | 12 | 2024 | 78 | 2.180 |
Why?
| | Antibodies, Viral | 11 | 2024 | 601 | 2.040 |
Why?
| | Herpesviridae Infections | 7 | 2024 | 134 | 2.010 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 46 | 2.010 |
Why?
| | Varicellovirus | 7 | 2024 | 16 | 1.800 |
Why?
| | Astrocytes | 4 | 2020 | 188 | 1.680 |
Why?
| | Adventitia | 5 | 2021 | 42 | 1.560 |
Why?
| | Antiviral Agents | 14 | 2022 | 710 | 1.510 |
Why?
| | Virus Activation | 7 | 2024 | 83 | 1.460 |
Why?
| | Antigens, Viral | 6 | 2021 | 174 | 1.450 |
Why?
| | Vascular Diseases | 6 | 2014 | 232 | 1.440 |
Why?
| | Herpesvirus 1, Human | 7 | 2024 | 87 | 1.370 |
Why?
| | Gene Expression Regulation, Viral | 4 | 2019 | 84 | 1.360 |
Why?
| | Virus Latency | 8 | 2024 | 78 | 1.350 |
Why?
| | Arteritis | 2 | 2021 | 24 | 1.320 |
Why?
| | Fibroblasts | 5 | 2021 | 934 | 1.300 |
Why?
| | Adrenal Glands | 2 | 2021 | 70 | 1.230 |
Why?
| | Cerebrovascular Disorders | 3 | 2021 | 89 | 1.090 |
Why?
| | Peptide Fragments | 3 | 2024 | 688 | 1.090 |
Why?
| | Exanthema | 6 | 2022 | 73 | 1.080 |
Why?
| | B7-H1 Antigen | 2 | 2019 | 189 | 1.010 |
Why?
| | Ganglia | 4 | 2019 | 17 | 0.900 |
Why?
| | Vasculitis, Central Nervous System | 3 | 2016 | 14 | 0.860 |
Why?
| | Host-Pathogen Interactions | 4 | 2020 | 346 | 0.850 |
Why?
| | Substance P | 2 | 2020 | 43 | 0.850 |
Why?
| | Immunoglobulin G | 7 | 2024 | 842 | 0.840 |
Why?
| | Humans | 85 | 2024 | 128020 | 0.830 |
Why?
| | Neuralgia, Postherpetic | 7 | 2014 | 40 | 0.830 |
Why?
| | Nervous System Diseases | 4 | 2016 | 251 | 0.820 |
Why?
| | Optic Neuropathy, Ischemic | 5 | 2015 | 30 | 0.820 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 9 | 0.720 |
Why?
| | Cell Death | 1 | 2022 | 342 | 0.690 |
Why?
| | Amyloid | 1 | 2021 | 83 | 0.690 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 16 | 0.680 |
Why?
| | Antigens, CD | 2 | 2019 | 481 | 0.670 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.660 |
Why?
| | Vascular Remodeling | 1 | 2021 | 181 | 0.660 |
Why?
| | Herpes Zoster Ophthalmicus | 2 | 2016 | 5 | 0.650 |
Why?
| | Aged, 80 and over | 17 | 2020 | 7029 | 0.650 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 8 | 0.630 |
Why?
| | Meningitis | 1 | 2020 | 80 | 0.620 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 36 | 0.620 |
Why?
| | Matrix Metalloproteinases | 2 | 2019 | 89 | 0.620 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 12 | 0.610 |
Why?
| | Cerebral Arterial Diseases | 2 | 2015 | 44 | 0.600 |
Why?
| | Pseudopodia | 1 | 2018 | 22 | 0.600 |
Why?
| | Cells, Cultured | 8 | 2021 | 4006 | 0.600 |
Why?
| | Myofibroblasts | 1 | 2019 | 119 | 0.590 |
Why?
| | Aged | 25 | 2024 | 21892 | 0.590 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 112 | 0.590 |
Why?
| | Cadherins | 1 | 2019 | 186 | 0.580 |
Why?
| | Middle Aged | 27 | 2024 | 30813 | 0.580 |
Why?
| | Asymptomatic Diseases | 2 | 2016 | 83 | 0.580 |
Why?
| | Cytokines | 3 | 2024 | 1984 | 0.560 |
Why?
| | Male | 38 | 2024 | 62758 | 0.540 |
Why?
| | Saliva | 3 | 2016 | 207 | 0.530 |
Why?
| | Burning Mouth Syndrome | 1 | 2016 | 5 | 0.530 |
Why?
| | Spinal Cord | 2 | 2018 | 353 | 0.530 |
Why?
| | SUNCT Syndrome | 1 | 2016 | 1 | 0.530 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1681 | 0.520 |
Why?
| | Trigeminal Ganglion | 4 | 2024 | 25 | 0.520 |
Why?
| | Macaca mulatta | 5 | 2024 | 147 | 0.500 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2019 | 940 | 0.490 |
Why?
| | Interleukin-6 | 1 | 2019 | 712 | 0.490 |
Why?
| | Vasculitis | 2 | 2015 | 59 | 0.480 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 196 | 0.480 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 840 | 0.480 |
Why?
| | Tunica Intima | 2 | 2012 | 80 | 0.460 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2014 | 13 | 0.460 |
Why?
| | Acyclovir | 4 | 2020 | 99 | 0.460 |
Why?
| | Stellate Ganglion | 1 | 2014 | 4 | 0.460 |
Why?
| | Ganglia, Sympathetic | 1 | 2014 | 14 | 0.450 |
Why?
| | Steroids | 1 | 2015 | 147 | 0.450 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 70 | 0.450 |
Why?
| | Herpesvirus 2, Human | 1 | 2014 | 28 | 0.450 |
Why?
| | Zoster Sine Herpete | 2 | 2012 | 2 | 0.440 |
Why?
| | Hippocampus | 1 | 2018 | 801 | 0.430 |
Why?
| | Transcription, Genetic | 3 | 2019 | 1403 | 0.430 |
Why?
| | Female | 33 | 2024 | 68017 | 0.430 |
Why?
| | Herpes Simplex | 3 | 2024 | 93 | 0.420 |
Why?
| | Aorta | 1 | 2016 | 408 | 0.420 |
Why?
| | Transcriptome | 3 | 2021 | 879 | 0.410 |
Why?
| | Leukocyte Common Antigens | 1 | 2013 | 81 | 0.410 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2013 | 51 | 0.410 |
Why?
| | Middle Cerebral Artery | 1 | 2012 | 42 | 0.400 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2508 | 0.390 |
Why?
| | Viral Proteins | 6 | 2024 | 321 | 0.350 |
Why?
| | Open Reading Frames | 4 | 2018 | 115 | 0.350 |
Why?
| | Gene Expression | 3 | 2020 | 1454 | 0.350 |
Why?
| | RNA, Messenger | 4 | 2020 | 2669 | 0.350 |
Why?
| | Cell Movement | 3 | 2019 | 933 | 0.340 |
Why?
| | RNA, Viral | 4 | 2012 | 615 | 0.340 |
Why?
| | Pemphigus | 1 | 2009 | 8 | 0.320 |
Why?
| | B-Cell Activating Factor | 1 | 2009 | 20 | 0.320 |
Why?
| | Antigens, CD20 | 1 | 2009 | 27 | 0.320 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 427 | 0.320 |
Why?
| | Animals | 20 | 2024 | 34487 | 0.300 |
Why?
| | Primary Cell Culture | 2 | 2022 | 157 | 0.290 |
Why?
| | Inflammation | 5 | 2022 | 2646 | 0.290 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 844 | 0.270 |
Why?
| | Alzheimer Disease | 2 | 2023 | 515 | 0.270 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2019 | 1043 | 0.270 |
Why?
| | Retinal Necrosis Syndrome, Acute | 3 | 2013 | 8 | 0.250 |
Why?
| | Adult | 15 | 2024 | 35177 | 0.250 |
Why?
| | Brain | 6 | 2024 | 2615 | 0.230 |
Why?
| | Lymphocyte Depletion | 2 | 2019 | 129 | 0.230 |
Why?
| | Leukocytes | 2 | 2018 | 303 | 0.230 |
Why?
| | Virus Replication | 3 | 2022 | 444 | 0.220 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 994 | 0.210 |
Why?
| | Magnetic Resonance Imaging | 7 | 2016 | 3371 | 0.200 |
Why?
| | Monkey Diseases | 2 | 2024 | 19 | 0.200 |
Why?
| | Microglia | 1 | 2024 | 228 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 129 | 0.200 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.200 |
Why?
| | Biopsy | 2 | 2016 | 1077 | 0.200 |
Why?
| | B-Lymphocytes | 3 | 2013 | 812 | 0.200 |
Why?
| | Antibodies, Monoclonal | 1 | 2009 | 1354 | 0.190 |
Why?
| | Adrenal Cortex | 1 | 2022 | 27 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.190 |
Why?
| | Immunosuppressive Agents | 2 | 2020 | 682 | 0.190 |
Why?
| | Tissue Fixation | 1 | 2021 | 33 | 0.190 |
Why?
| | Risk Factors | 5 | 2021 | 9696 | 0.190 |
Why?
| | Paraffin Embedding | 1 | 2021 | 28 | 0.190 |
Why?
| | Electrophoresis, Capillary | 2 | 2013 | 20 | 0.190 |
Why?
| | Plasma | 1 | 2023 | 199 | 0.190 |
Why?
| | Macaca fascicularis | 1 | 2021 | 49 | 0.190 |
Why?
| | Viral Envelope Proteins | 2 | 2020 | 80 | 0.180 |
Why?
| | Formaldehyde | 1 | 2021 | 57 | 0.180 |
Why?
| | Histological Techniques | 1 | 2021 | 39 | 0.180 |
Why?
| | Autoantibodies | 1 | 2009 | 1461 | 0.180 |
Why?
| | Cerebral Angiography | 2 | 2012 | 109 | 0.180 |
Why?
| | DNA, Complementary | 1 | 2021 | 266 | 0.180 |
Why?
| | Cell Line | 4 | 2020 | 2736 | 0.180 |
Why?
| | Skin | 2 | 2019 | 711 | 0.170 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 8 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 67 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 75 | 0.170 |
Why?
| | Interleukins | 1 | 2022 | 240 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 68 | 0.170 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 467 | 0.170 |
Why?
| | Intracellular Space | 1 | 2020 | 70 | 0.160 |
Why?
| | Claudin-1 | 1 | 2019 | 21 | 0.160 |
Why?
| | Protein Aggregates | 1 | 2020 | 67 | 0.160 |
Why?
| | Prevalence | 3 | 2015 | 2541 | 0.160 |
Why?
| | Extracellular Space | 1 | 2020 | 119 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 323 | 0.160 |
Why?
| | Tacrolimus | 1 | 2020 | 140 | 0.160 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 108 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 86 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2020 | 3324 | 0.160 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 13 | 0.160 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 46 | 0.160 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 29 | 0.160 |
Why?
| | Spinal Cord Diseases | 2 | 2010 | 40 | 0.160 |
Why?
| | Macrophages | 3 | 2024 | 1460 | 0.160 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 9 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 11 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2013 | 1408 | 0.150 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 87 | 0.150 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 48 | 0.150 |
Why?
| | Coculture Techniques | 1 | 2019 | 225 | 0.150 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 92 | 0.150 |
Why?
| | DNA | 3 | 2021 | 1392 | 0.150 |
Why?
| | Risk | 1 | 2020 | 850 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 238 | 0.140 |
Why?
| | Herpes Zoster Vaccine | 2 | 2011 | 162 | 0.140 |
Why?
| | Fatal Outcome | 2 | 2015 | 299 | 0.140 |
Why?
| | Aortic Diseases | 1 | 2018 | 114 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 226 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1185 | 0.140 |
Why?
| | Protein Isoforms | 1 | 2018 | 377 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5268 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 518 | 0.130 |
Why?
| | Aortitis | 1 | 2016 | 10 | 0.130 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 380 | 0.130 |
Why?
| | Virology | 2 | 2013 | 21 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 539 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 323 | 0.130 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2015 | 18 | 0.130 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2015 | 26 | 0.120 |
Why?
| | Neuroglia | 1 | 2016 | 165 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2015 | 55 | 0.120 |
Why?
| | Eye Infections, Viral | 1 | 2015 | 7 | 0.120 |
Why?
| | Histocytochemistry | 1 | 2015 | 82 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 899 | 0.120 |
Why?
| | Functional Laterality | 1 | 2016 | 218 | 0.120 |
Why?
| | Neurons | 2 | 2016 | 1445 | 0.120 |
Why?
| | Pheochromocytoma | 1 | 2016 | 57 | 0.120 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2015 | 112 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2016 | 83 | 0.120 |
Why?
| | STAT2 Transcription Factor | 1 | 2014 | 3 | 0.120 |
Why?
| | Vision Disorders | 2 | 2012 | 135 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2023 | 1164 | 0.110 |
Why?
| | Down-Regulation | 1 | 2016 | 630 | 0.110 |
Why?
| | Internationality | 1 | 2015 | 149 | 0.110 |
Why?
| | Nanoparticles | 1 | 2018 | 368 | 0.110 |
Why?
| | Interferon-beta | 1 | 2014 | 87 | 0.110 |
Why?
| | Medulla Oblongata | 1 | 2013 | 31 | 0.110 |
Why?
| | Risk Assessment | 1 | 2023 | 3223 | 0.110 |
Why?
| | Fluorometry | 1 | 2013 | 17 | 0.110 |
Why?
| | Pons | 1 | 2013 | 30 | 0.110 |
Why?
| | Age Factors | 2 | 2014 | 3100 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.110 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 598 | 0.100 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 94 | 0.100 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 344 | 0.100 |
Why?
| | Interferon-alpha | 1 | 2014 | 192 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1020 | 0.100 |
Why?
| | Dementia, Multi-Infarct | 1 | 2012 | 1 | 0.100 |
Why?
| | Myelitis | 1 | 2014 | 98 | 0.100 |
Why?
| | Blood Vessels | 1 | 2014 | 181 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 420 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 64 | 0.100 |
Why?
| | Optic Nerve | 1 | 2012 | 64 | 0.100 |
Why?
| | Methylprednisolone | 1 | 2012 | 82 | 0.100 |
Why?
| | RNA | 1 | 2019 | 881 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2425 | 0.100 |
Why?
| | Facial Paralysis | 1 | 2011 | 17 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1663 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2019 | 2337 | 0.090 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2011 | 56 | 0.090 |
Why?
| | Fetus | 1 | 2015 | 760 | 0.090 |
Why?
| | Hyperplasia | 1 | 2011 | 170 | 0.090 |
Why?
| | Cerebrospinal Fluid | 1 | 2011 | 89 | 0.090 |
Why?
| | MicroRNAs | 2 | 2024 | 674 | 0.090 |
Why?
| | RNA Stability | 1 | 2011 | 100 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2011 | 173 | 0.080 |
Why?
| | Herpes Zoster Oticus | 1 | 2010 | 2 | 0.080 |
Why?
| | Adolescent | 4 | 2024 | 20158 | 0.080 |
Why?
| | Comorbidity | 1 | 2015 | 1537 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1047 | 0.080 |
Why?
| | Phosphorylation | 1 | 2014 | 1681 | 0.080 |
Why?
| | Immunocompromised Host | 1 | 2011 | 195 | 0.080 |
Why?
| | Cranial Nerve Diseases | 1 | 2010 | 41 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2011 | 245 | 0.080 |
Why?
| | Neural Stem Cells | 1 | 2011 | 141 | 0.080 |
Why?
| | Receptors, CCR1 | 1 | 2009 | 4 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2009 | 3 | 0.080 |
Why?
| | Lung | 3 | 2019 | 3745 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 3874 | 0.080 |
Why?
| | Actins | 1 | 2011 | 401 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2016 | 2706 | 0.080 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 87 | 0.080 |
Why?
| | History, 21st Century | 1 | 2009 | 177 | 0.080 |
Why?
| | Laboratories | 1 | 2009 | 109 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 171 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 285 | 0.070 |
Why?
| | Rituximab | 1 | 2009 | 162 | 0.070 |
Why?
| | DNA Primers | 1 | 2009 | 509 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1192 | 0.070 |
Why?
| | Chickenpox Vaccine | 1 | 2007 | 71 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2134 | 0.070 |
Why?
| | Pain | 1 | 2012 | 748 | 0.070 |
Why?
| | Spinal Cord Ischemia | 1 | 2007 | 55 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2008 | 220 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2614 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2820 | 0.060 |
Why?
| | Registries | 1 | 2014 | 1873 | 0.060 |
Why?
| | Analgesics | 1 | 2007 | 163 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 1934 | 0.060 |
Why?
| | Time Factors | 3 | 2014 | 6479 | 0.060 |
Why?
| | Disease Models, Animal | 3 | 2024 | 3936 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1010 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2015 | 5034 | 0.060 |
Why?
| | Disease Progression | 4 | 2014 | 2598 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1921 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1813 | 0.060 |
Why?
| | Recurrence | 2 | 2021 | 993 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 93 | 0.050 |
Why?
| | Mice | 4 | 2024 | 16574 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 1896 | 0.050 |
Why?
| | Presenilin-1 | 1 | 2022 | 31 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2509 | 0.050 |
Why?
| | Central Nervous System | 1 | 2024 | 254 | 0.050 |
Why?
| | Fructose | 1 | 2023 | 106 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Uric Acid | 1 | 2023 | 160 | 0.050 |
Why?
| | Young Adult | 2 | 2024 | 12282 | 0.050 |
Why?
| | Signal Transduction | 1 | 2014 | 4812 | 0.040 |
Why?
| | Olfactory Bulb | 1 | 2022 | 136 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 886 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 185 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 228 | 0.040 |
Why?
| | Infant | 2 | 2024 | 8912 | 0.040 |
Why?
| | Neuroimaging | 1 | 2021 | 278 | 0.040 |
Why?
| | Child, Preschool | 2 | 2024 | 10378 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2018 | 295 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 245 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 983 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 350 | 0.040 |
Why?
| | Plasmids | 1 | 2018 | 354 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 221 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 162 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 468 | 0.030 |
Why?
| | Child | 3 | 2024 | 20636 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1008 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2019 | 465 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2066 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1227 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 475 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 847 | 0.030 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 118 | 0.030 |
Why?
| | Visual Acuity | 1 | 2015 | 322 | 0.030 |
Why?
| | Basal Ganglia Cerebrovascular Disease | 1 | 2012 | 3 | 0.030 |
Why?
| | Apraxias | 1 | 2012 | 7 | 0.030 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2012 | 8 | 0.030 |
Why?
| | Pupil Disorders | 1 | 2012 | 5 | 0.030 |
Why?
| | Dysarthria | 1 | 2012 | 9 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 384 | 0.030 |
Why?
| | Postmortem Changes | 1 | 2012 | 16 | 0.030 |
Why?
| | Immediate-Early Proteins | 1 | 2012 | 51 | 0.020 |
Why?
| | Valine | 1 | 2012 | 80 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2012 | 227 | 0.020 |
Why?
| | Gait Disorders, Neurologic | 1 | 2012 | 44 | 0.020 |
Why?
| | Thalamus | 1 | 2012 | 84 | 0.020 |
Why?
| | Prednisone | 1 | 2012 | 230 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2011 | 14 | 0.020 |
Why?
| | Thiouridine | 1 | 2011 | 1 | 0.020 |
Why?
| | Memory Disorders | 1 | 2012 | 156 | 0.020 |
Why?
| | Phosphonoacetic Acid | 1 | 2011 | 10 | 0.020 |
Why?
| | Subarachnoid Space | 1 | 2011 | 8 | 0.020 |
Why?
| | Half-Life | 1 | 2011 | 149 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 235 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 370 | 0.020 |
Why?
| | Alphaherpesvirinae | 1 | 2009 | 1 | 0.020 |
Why?
| | Vero Cells | 1 | 2009 | 65 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2012 | 1012 | 0.020 |
Why?
| | Immunization | 1 | 2011 | 411 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 961 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 630 | 0.020 |
Why?
| | HeLa Cells | 1 | 2009 | 605 | 0.020 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2007 | 35 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2007 | 96 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 69 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1690 | 0.020 |
Why?
| | Treatment Failure | 1 | 2007 | 338 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 261 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 2460 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3168 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3682 | 0.010 |
Why?
|
|
Nagel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|